Late onset of Huntington's disease
- PMID: 3159849
- PMCID: PMC1028368
- DOI: 10.1136/jnnp.48.6.530
Late onset of Huntington's disease
Abstract
Twenty-five patients with late-onset Huntington's disease were studied; motor impairment appeared at age 50 years or later. The average age at onset of chorea was 57.5 years, with an average age at diagnosis of 63.1 years. Approximately 25% of persons affected by Huntington's disease exhibit late onset. A preponderance of maternal transmission was noted in late-onset Huntington's disease. The clinical features resembled those of mid-life onset Huntington's disease but progressed more slowly. Neuropathological evaluation of two cases reveal less severe neuronal atrophy than for mid-life onset disease.
Similar articles
-
Late-onset Huntington's disease: a clinical and molecular study.Age Ageing. 1994 Nov;23(6):445-8. doi: 10.1093/ageing/23.6.445. Age Ageing. 1994. PMID: 9231935
-
Late-onset Huntington's disease: diagnostic and prognostic considerations.Parkinsonism Relat Disord. 2014 Jul;20(7):726-30. doi: 10.1016/j.parkreldis.2014.03.017. Epub 2014 Mar 27. Parkinsonism Relat Disord. 2014. PMID: 24721491
-
Chorea in the Elderly: A Differential Diagnosis and Case Report of Late-Onset Huntington's Disease in an Octogenarian.J Huntingtons Dis. 2023;12(4):377-380. doi: 10.3233/JHD-230596. J Huntingtons Dis. 2023. PMID: 38073394
-
What do we know about Late Onset Huntington's Disease?J Huntingtons Dis. 2017;6(2):95-103. doi: 10.3233/JHD-170247. J Huntingtons Dis. 2017. PMID: 28671137 Free PMC article. Review.
-
[Huntington's disease].Tidsskr Nor Laegeforen. 2008 Oct 9;128(19):2214-7. Tidsskr Nor Laegeforen. 2008. PMID: 18846148 Review. Norwegian.
Cited by
-
[Choreatic syndrome at 79 years old: late manifestation of Huntington's chorea].Nervenarzt. 2013 Dec;84(12):1502-3. doi: 10.1007/s00115-013-3948-8. Nervenarzt. 2013. PMID: 24264646 German. No abstract available.
-
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection.Curr Neuropharmacol. 2020;18(11):1076-1091. doi: 10.2174/1570159X18666200525020259. Curr Neuropharmacol. 2020. PMID: 32448104 Free PMC article. Review.
-
Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.J Neurol. 2025 Mar 6;272(3):254. doi: 10.1007/s00415-025-12966-9. J Neurol. 2025. PMID: 40047995 Free PMC article.
-
Untangling the Role of Tau in Huntington's Disease Pathology.J Huntingtons Dis. 2023;12(1):15-29. doi: 10.3233/JHD-220557. J Huntingtons Dis. 2023. PMID: 36806513 Free PMC article. Review.
-
Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.Front Cell Neurosci. 2020 Jan 17;13:574. doi: 10.3389/fncel.2019.00574. eCollection 2019. Front Cell Neurosci. 2020. PMID: 32009905 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical